2025 Virtual Candidate Training

Join us for one or both sessions in our two-part series:

Session 1 (10/29, 12-1pm):

• Overview: How mifepristone and misoprostol work together
• Distribution: In-clinic, telehealth, mail order, pharmacy access, and FDA rule changes
• Medical Oversight: Lackthereof and lack of follow-up care
• Complications: Types of complications, rates of complications, underreported ER visits

Session 2 (11/5, 12-1pm):

• Informed Consent Gaps: What women aren’t told—gestational limits, side effects, reversibility 
• Case Studies: Real-world outcomes and patient experiences 
• Expanded Access Outcomes: Data and trends where access increased (U.S. & abroad) 
• Advocacy & Messaging: How to discuss the issue with clarity, compassion, and credibility